MYCN associates with EZH2, a methyltransferase and a member of the polycomb repressor complex 2 (PRC2) to repress the NB tumor suppressor gene CLU through a bivalent modification of the chromatin at the CLU promoter (78). The gene discussed is MYCN; the disease is neoplasm.